Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (R43/R44)

Post Date

May 9th 2014

Application Due Date

August 15th 2014

Funding Opportunity Number

RFA-ES-14-005

CFDA Number(s)

93.113

Funding Instrument Type(s)

Grant

Funding Activity Categories

Environment
Health

Eligibility Categories

Small Businesses

Other Eligible Applicants include the following: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria: 1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; 2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture; 3.Ф(i) SBIR and STTR.ФBe a concern which is more than 50% directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50% directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these; OR (ii) SBIR-only.ФBe a concern which is more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these.ФNo single venture capital operating company, hedge fund, or private equity firm may own more than 50% of the concern; OR (iii) SBIR and STTR.ФBe a joint venture in which each entity to the joint venture must meet the requirements set forth in paragraph 3 (i) or 3 (ii) of this section. A joint venture that includes one or more concerns that meet the requirements of paragraph (ii) of this section must comply with _ 121.705(b) concerning registration and proposal requirements. 4.ФHas, including its affiliates, not more than 500 employees. If the concern is more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these falls under 3 (ii) or 3 (iii) above, see Section IV. Application and Submission Information for additional instructions regarding required application certification.

Funding

• Estimated Total Funding:

  $3000000

• Award Range:

  $None - $None

Grant Description

This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop point-of-care or benchtop instruments, or other laboratory-based approaches for the characterization of major classes of analytes that include known and suspected toxicants and their major metabolites in human biological samples, including blood, urine, and saliva, which are likely to be available from both prospective and retrospective epidemiological cohorts. The focus of technology development is on the ability to detect multiple chemical analytes with high sensitivity and specificity in low volumes of biological specimens.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-14-005.html